These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24312282)

  • 1. Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain.
    Kravitz E; Gaisler-Salomon I; Biegon A
    PLoS One; 2013; 8(11):e81244. PubMed ID: 24312282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.
    Geddes JW; Chang-Chui H; Cooper SM; Lott IT; Cotman CW
    Brain Res; 1986 Dec; 399(1):156-61. PubMed ID: 2879613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.
    Bi H; Sze CI
    J Neurol Sci; 2002 Aug; 200(1-2):11-8. PubMed ID: 12127670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J; Brunner LC; Geddes JW; Choe W; Cotman CW
    Neuroscience; 1992 Jul; 49(1):45-61. PubMed ID: 1407551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease.
    Sze C; Bi H; Kleinschmidt-DeMasters BK; Filley CM; Martin LJ
    J Neurol Sci; 2001 Jan; 182(2):151-9. PubMed ID: 11137521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide.
    James ML; Belichenko NP; Nguyen TV; Andrews LE; Ding Z; Liu H; Bodapati D; Arksey N; Shen B; Cheng Z; Wyss-Coray T; Gambhir SS; Longo FM; Chin FT
    J Nucl Med; 2015 Feb; 56(2):311-6. PubMed ID: 25613536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal N-methyl-D-aspartate and kainate binding in response to entorhinal cortex aspiration or 192 IgG-saporin lesions of the basal forebrain.
    Nicolle MM; Shivers A; Gill TM; Gallagher M
    Neuroscience; 1997 Apr; 77(3):649-59. PubMed ID: 9070742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.
    Xu J; Sun J; Perrin RJ; Mach RH; Bales KR; Morris JC; Benzinger TLS; Holtzman DM
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1423-1434. PubMed ID: 31402620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease.
    Amani M; Zolghadrnasab M; Salari AA
    Physiol Behav; 2019 Apr; 202():52-61. PubMed ID: 30641081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity in hippocampal excitatory amino acid receptors in Alzheimer's disease.
    Geddes JW; Cotman CW
    Neurosci Res; 1986 Sep; 3(6):672-8. PubMed ID: 2877425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of hippocampal [3H]TCP binding in Alzheimer's disease.
    Maragos WF; Chu DC; Young AB; D'Amato CJ; Penney JB
    Neurosci Lett; 1987 Mar; 74(3):371-6. PubMed ID: 3031556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.
    Penney JB; Maragos WF; Greenamyre JT; Debowey DL; Hollingsworth Z; Young AB
    J Neurol Neurosurg Psychiatry; 1990 Apr; 53(4):314-20. PubMed ID: 2160518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex.
    Carlson MD; Penney JB; Young AB
    Neurobiol Aging; 1993; 14(4):343-52. PubMed ID: 7690114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice.
    Timmer NM; Metaxas A; van der Stelt I; Kluijtmans LA; van Berckel BN; Verbeek MM
    J Alzheimers Dis; 2014; 39(1):89-101. PubMed ID: 24145381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain.
    Cyr M; Ghribi O; Di Paolo T
    J Neuroendocrinol; 2000 May; 12(5):445-52. PubMed ID: 10792584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Gessi S; Poloni TE; Negro G; Varani K; Pasquini S; Vincenzi F; Borea PA; Merighi S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App
    Biechele G; Wind K; Blume T; Sacher C; Beyer L; Eckenweber F; Franzmeier N; Ewers M; Zott B; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Tahirovic S; Willem M; Bartenstein P; Cumming P; Rominger A; Herms J; Brendel M
    Neuroimage; 2021 Apr; 230():117707. PubMed ID: 33385560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
    Bonkale WL; Cowburn RF; Ohm TG; Bogdanovic N; Fastbom J
    Brain Res; 1999 Feb; 818(2):383-96. PubMed ID: 10082824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.